Synthesis and COX-2 Inhibitory Activity of 4-[(E)-2-(4-Oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)ethenyl]benzene-1-sulfonamide and Its Analogs

被引:6
|
作者
Hayun [1 ]
Hudiyono, Sumi [2 ]
Hanafi, Muhammad [3 ]
Yanuar, Arry [1 ]
机构
[1] Univ Indonesia, Fac Pharm, Depok 16424, West Java, Indonesia
[2] Univ Indonesia, Fac Nat Sci, Dept Chem, Depok 16424, West Java, Indonesia
[3] Indonesian Inst Sci, Res Ctr Chem, Serpong 15314, West Java, Indonesia
来源
PHARMACEUTICALS | 2012年 / 5卷 / 12期
关键词
quinazolin-4-one; benzenesulfonamide; COX-2; inhibitor;
D O I
10.3390/ph5121282
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Some novel 3-phenyl-2-[(E)-2-phenylethenyl]-3,4-dihydroquinazolin-4-one derivatives possessing para-sulfonamides groups on the phenyl ring of the 2-phenylethenyl moiety have been synthesized and their COX-2 inhibitory activity evaluated. The stuctures of the synthesized compounds were confirmed on the basis of FT-IR, H-1-NMR, C-13-NMR and mass spectral data. The COX-2 inhibition screening assay revealed that 4-[(E)-2-{3-(4-methoxyphenyl)-4-oxo-3,4-dihydroquinazolin-2-yl}ethenyl]benzene-1-sulfonamide had a maximum COX-2 inhibition (47.1%), at a concentration of 20 mu M.
引用
收藏
页码:1282 / 1290
页数:9
相关论文
共 50 条
  • [21] Synthesis of Novel New 2-(2-(4-((3,4-Dihydro-4-oxo-3-aryl quinazolin-2-yl)methyl)piperazin-1-yl)acetoyloxy)-2-phenyl Acetic Acid Esters
    Acharyulu, Palle V. R.
    Dubey, P. K.
    Reddy, P. V. V. Prasada
    Suresh, Thatipally
    SYNTHETIC COMMUNICATIONS, 2009, 39 (18) : 3217 - 3231
  • [22] Development of 2-(2-(3-(4-([18F]Fluoromethoxy-d2)phenyl)-7-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)ethyl)-4-isopropoxyisoindoline-1,3-dione for Positron-Emission-Tomography Imaging of Phosphodiesterase 10A in the Brain
    Mori, Wakana
    Yamasaki, Tomoteru
    Fujinaga, Masayuki
    Ogawa, Masanao
    Zhang, Yiding
    Hatori, Akiko
    Xie, Lin
    Kumata, Katsushi
    Wakizaka, Hidekatsu
    Kurihara, Yusuke
    Ohkubo, Takayuki
    Nengaki, Nobuki
    Zhang, Ming-Rong
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (02) : 688 - 698
  • [23] 3-{2-[(3-{(E)-2-[4-(Dimethylamino)phenyl]ethenyl}quinoxalin-2-yl)oxy]ethyl}-1,3-oxazolidin-2-one monohydrate
    Ramli, Youssef
    Zouihri, Hafid
    Essassi, El Mokhtar
    Ng, Seik Weng
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2012, 68
  • [24] Exploration of N-alkyl-2-[(4-oxo-3-(4-sulfamoylphenyl)-3,4-dihydroquinazolin-2-yl)thio] acetamide derivatives as anticancer and radiosensitizing agents
    Soliman, Aiten M.
    Ghorab, Mostafa M.
    BIOORGANIC CHEMISTRY, 2019, 88
  • [25] Synthesis and photodynamic activity of new 5-[(E)-2-(3-alkoxy-1-phenyl-1H-pyrazol-4-yl)ethenyl]-2-phenyl-3H-indoles
    Varvuolyte, Gabriele
    Reznickova, Eva
    Bieliauskas, Aurimas
    Kleiziene, Neringa
    Vojackova, Veronika
    Opichalova, Alena
    Zukauskaite, Asta
    Krystof, Vladimir
    Sackus, Algirdas
    ARCHIV DER PHARMAZIE, 2024, 357 (10)
  • [26] 2-[2-(2-Anilino-4-oxo-3,4-dihydroquinazolin-3-yl)phenoxy]-3-phenylquinazolin-4(3H)-one methanol hemisolvate
    Gao, Tao
    Chen, Xiao-Bao
    Yang, Xu-Hong
    Wang, Xiang
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2010, 66 : O2075 - U1716
  • [27] (E,E,E,E)-2,3,5,6-Tetrakis{2-[4-(dimethylamino)phenyl]ethenyl}pyrazine
    Schmitt, Volker
    Schollmeyer, Dieter
    Detert, Heiner
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O1553 - U1891
  • [28] Synthesis of some functionalized 3-(4-thioxo-3,4-dihydroquinazolin-2-Yl) acrylic acid of pharmaceutical interest
    Aly, AA
    PHOSPHORUS SULFUR AND SILICON AND THE RELATED ELEMENTS, 2003, 178 (11) : 2415 - 2429
  • [29] 4-[2-(3,4-Dimethoxyphenyl)ethenyl] -1-methylpyridinium tetraphenylborate
    Zhang, De-Chun
    Ge, Li-Qin
    Zhang, Tian-Zhu
    Zhang, Yan-Qiu
    Yu, Kai-Bei
    Acta Crystallographica, Section C: Crystal Structure Communications, 1999, 55 (11): : 1938 - 1939
  • [30] 4-[2-(3,4-Dimethoxyphenyl)ethenyl]-1-methylpyridinium tetrafluoroborate
    Suzhou Univ, Suzhou, China
    Acta Crystallogr Sect C Cryst Struct Commun, pt 1 (138-140):